A Single-Blind, Randomised, Parallel-Group, Single-Centre Pharmacokinetic and pH-Monitoring Study of Esomeprazole in Infants up to 24 Months of Age

Registry ID

EUCTR2012-001159-37

Source registry

EUCTR

Phase

PHASE2

Sponsor

AstraZeneca AB

Last update

2026-08-16

Conditions

• Gastroesophageal Reflux Disease

Summary

Primary objectives To assess the pharmacokinetics of esomeprazole and its efficacy in controlling intragastric pH in infants.

Related clinical trials

• Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study of Multidimensional Interventions and Health Impacts
• A Retrospective Analysis of Patients With Gastroesophageal Reflux Disease Based on a Prospective Clinical Dataset
• Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
• Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)
• Domperidone in Treating Patients With Gastrointestinal Disorders
• Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer

View on source registry